L-알라닌,N-[(S)-하이드록시페녹시포스피닐]-,1-메틸에틸에스테르,(P→3'),(P'→5')-디에스테르(2'R)-2'-데옥시-2'포함)-플루오로-2'-메틸우리딘
|
|
L-알라닌,N-[(S)-하이드록시페녹시포스피닐]-,1-메틸에틸에스테르,(P→3'),(P'→5')-디에스테르(2'R)-2'-데옥시-2'포함)-플루오로-2'-메틸우리딘 속성
- 밀도
- 1.37±0.1 g/cm3(Predicted)
- 저장 조건
- Store at -20°C
- 용해도
- DMSO에 용해됨
- 물리적 상태
- Solid
- 산도 계수 (pKa)
- 9.39±0.10(Predicted)
- 색상
- Light yellow to yellow
안전
L-알라닌,N-[(S)-하이드록시페녹시포스피닐]-,1-메틸에틸에스테르,(P→3'),(P'→5')-디에스테르(2'R)-2'-데옥시-2'포함)-플루오로-2'-메틸우리딘 C화학적 특성, 용도, 생산
용도
Sofosbuvir ImpurityL-알라닌,N-[(S)-하이드록시페녹시포스피닐]-,1-메틸에틸에스테르,(P→3'),(P'→5')-디에스테르(2'R)-2'-데옥시-2'포함)-플루오로-2'-메틸우리딘 준비 용품 및 원자재
원자재
준비 용품
L-알라닌,N-[(S)-하이드록시페녹시포스피닐]-,1-메틸에틸에스테르,(P→3'),(P'→5')-디에스테르(2'R)-2'-데옥시-2'포함)-플루오로-2'-메틸우리딘 공급 업체
글로벌( 50)공급 업체
공급자 | 전화 | 이메일 | 국가 | 제품 수 | 이점 |
---|---|---|---|---|---|
Standardpharm Co. Ltd. | 86-714-3992388 |
overseasales1@yongstandards.com | United States | 14335 | 58 |
TargetMol Chemicals Inc. | +1-781-999-5354 +1-00000000000 |
marketing@targetmol.com | United States | 19892 | 58 |
BOC Sciences | 16314854226; +16314854226 |
inquiry@bocsci.com | United States | 19743 | 58 |
Hangzhou Huarong Pharm Co., Ltd. | 571-86758373 +8613588754946 |
sales@huarongpharm.com | CHINA | 3149 | 58 |
sgtlifesciences pvt ltd | +8617013299288 |
dj@sgtlifesciences.com | China | 12382 | 58 |
China National Standard Pharmaceutical Corporation Limited | +8615391658522 |
overseasales@yongstandards.com | China | 11927 | 58 |
Beijing Comparison Pharmaceutical Technology Co., Ltd | 010-010-52878169 15801002657 |
sales@bjcomparison.com | China | 4915 | 58 |
MedChemexpress LLC | 021-58955995 |
sales@medchemexpress.cn | United States | 4863 | 58 |
Wuxi Zhongkun Biochemical Technology Co., Ltd. | 0510-85629785 18013409632 |
sales@reading-chemicals.com | China | 15185 | 58 |
Haixi Pharmaceuticals | 0591-87519936-3020 18060579623 |
yuanhong.lai@hxpharma.com | China | 13 | 65 |
L-알라닌,N-[(S)-하이드록시페녹시포스피닐]-,1-메틸에틸에스테르,(P→3'),(P'→5')-디에스테르(2'R)-2'-데옥시-2'포함)-플루오로-2'-메틸우리딘 관련 검색:
Sofosbuvir Impurity
Sofosbuvir
(2R,3R,4R,5R)-5-(4-benzaMido-2-oxopyriMidin-1(2H)-yl)-2-((benzoyloxy)Methyl)-4-chloro-4-Methyltetrahydrofuran-3-yl benzoate
1-((2S,3R,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)-3-methyltetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione
Sofosbuvir metabolites
D-Alanine, N-[[P(R),2'R]-2'-deoxy-2'-fluoro-2'-Methyl-P-phenyl-5'-uridylyl]-, 1-Methylethyl ester
SofosBuvir impurity 44
1-((2R,3R,4R,5R)-3-chloro-4-hydroxy-5-(hydroxyMethyl)-3-Methyltetrahydrofuran-2-yl)pyriMidine-2,4(1H,3H)-dione
Sofosbuvir impurity D
SofosBuvir Impurity 52
PSI-7976
N-[(S)-(2,3,4,5,6-pentafluorophenoxy)phenoxyphosphinyl]-L-alanine 1-Methylethyl ester
Sofosbuvir Impurity 67
SofosBuvir Impurity 14
(S)-methyl 2-(((S)-(((2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)amino)propanoate
(2R,3R,4R,5S)-5-(4-benzaMido-2-oxopyriMidin-1(2H)-yl)-2-((benzoyloxy)Methyl)-4-fluoro-4-Methyltetrahydrofuran-3-yl benzoate
SofosBuvir Impurity 50
Sofosbuvir Impurity23